tirzepatide buildleaf BuildLeaf™ Tirzepatide GLP-1 Herbal Oral Liquid Leaf Buildleaf tirzepatide GLP-1 herbal

Self-funded employers can modify their plan design at any time

This information helps guide monitoring intensity and prophylactic decisions

At very low reconstitution volumes, either use a low dead space syringe or account for this in your calculations

If combining with an active treatment, timing recommendations should come from your provider

(All compounded medication purchases are considered part of the GLP-1 ID program.) *Based on Ivims published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks